113 related articles for article (PubMed ID: 36920717)
1. The Effect of Berberine Follow by Blue Light Irradiation and Valproic Acid on the Growth Inhibition of MDA-MB-231 Breast Cancer Cells.
Meschi M; Khorsandi K; Kianmehr Z
Appl Biochem Biotechnol; 2023 Nov; 195(11):6752-6767. PubMed ID: 36920717
[TBL] [Abstract][Full Text] [Related]
2. Methylene blue photodynamic therapy induces selective and massive cell death in human breast cancer cells.
Dos Santos AF; Terra LF; Wailemann RA; Oliveira TC; Gomes VM; Mineiro MF; Meotti FC; Bruni-Cardoso A; Baptista MS; Labriola L
BMC Cancer; 2017 Mar; 17(1):194. PubMed ID: 28298203
[TBL] [Abstract][Full Text] [Related]
3. Methylene blue and photodynamic therapy for melanomas: Inducing different rates of cell death (necrosis and apoptosis) in B16-F10 melanoma cells according to methylene blue concentration and energy dose.
Grande MPD; Miyake AM; Nagamine MK; Leite JVP; da Fonseca IIM; Massoco CO; Dagli MLZ
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102635. PubMed ID: 34798348
[TBL] [Abstract][Full Text] [Related]
4. Photodynamic therapy with zinc phthalocyanine enhances the anti-cancer effect of tamoxifen in breast cancer cell line: Promising combination treatment against triple-negative breast cancer?
Rajabi N; Mohammadnejad F; Doustvandi MA; Shadbad MA; Amini M; Tajalli H; Mokhtarzadeh A; Baghbani E; Silvestris N; Baradaran B
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103212. PubMed ID: 36436735
[TBL] [Abstract][Full Text] [Related]
5. Investigation of LED-based photodynamic therapy efficiency on breast cancer cells.
Kamanlı AF; Yıldız MZ; Özyol E; Deveci Ozkan A; Sozen Kucukkara E; Guney Eskiler G
Lasers Med Sci; 2021 Apr; 36(3):563-569. PubMed ID: 32577931
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of photodynamic treatment and doxorubicin on triple negative breast cancer cells.
Yousefi Sadeghloo A; Khorsandi K; Kianmehr Z
Photochem Photobiol Sci; 2020 Nov; 19(11):1580-1589. PubMed ID: 33030191
[TBL] [Abstract][Full Text] [Related]
7. Graphene oxide-methylene blue nanocomposite in photodynamic therapy of human breast cancer.
Hosseinzadeh R; Khorsandi K; Hosseinzadeh G
J Biomol Struct Dyn; 2018 Jul; 36(9):2216-2223. PubMed ID: 28681663
[TBL] [Abstract][Full Text] [Related]
8. AIE-based gold nanostar-berberine dimer nanocomposites for PDT and PTT combination therapy toward breast cancer.
Li RT; Chen M; Yang ZC; Chen YJ; Huang NH; Chen WH; Chen J; Chen JX
Nanoscale; 2022 Jul; 14(27):9818-9831. PubMed ID: 35771232
[TBL] [Abstract][Full Text] [Related]
9. Optimization of 5-aminolevulinic acid-based photodynamic therapy protocol for breast cancer cells.
Guney Eskiler G; Deveci Ozkan A; Sozen Kucukkara E; Kamanlı AF; Gunoğlu B; Yıldız MZ
Photodiagnosis Photodyn Ther; 2020 Sep; 31():101854. PubMed ID: 32512246
[TBL] [Abstract][Full Text] [Related]
10. Methylene blue, curcumin and ion pairing nanoparticles effects on photodynamic therapy of MDA-MB-231 breast cancer cell.
Hosseinzadeh R; Khorsandi K
Photodiagnosis Photodyn Ther; 2017 Jun; 18():284-294. PubMed ID: 28300724
[TBL] [Abstract][Full Text] [Related]
11. Nanoparticles of methylene blue enhance photodynamic therapy.
Jesus VPS; Raniero L; Lemes GM; Bhattacharjee TT; Caetano Júnior PC; Castilho ML
Photodiagnosis Photodyn Ther; 2018 Sep; 23():212-217. PubMed ID: 29928992
[TBL] [Abstract][Full Text] [Related]
12. Antitumor effect of conditioned media derived from murine MSCs and 5-aminolevulinic acid (5-ALA) mediated photodynamic therapy in breast cancer in vitro.
Mohammadpour H; Majidzadeh-A K
Photodiagnosis Photodyn Ther; 2015 Jun; 12(2):238-43. PubMed ID: 25721458
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and characterization of novel Schiff base-silicon (IV) phthalocyanine complex for photodynamic therapy of breast cancer cell lines.
Sarı C; Değirmencioğlu İ; Eyüpoğlu FC
Photodiagnosis Photodyn Ther; 2023 Jun; 42():103504. PubMed ID: 36907257
[TBL] [Abstract][Full Text] [Related]
14. In silico analysis of the association of hsa-miR-16 expression and cell survival in MDA-MB-231 breast cancer cells subjected to photodynamic therapy.
Cupido-Sánchez MG; Herrera-González NE; Mendoza CCB; Hernández MLM; Ramón-Gallegos E
Photodiagnosis Photodyn Ther; 2021 Mar; 33():102106. PubMed ID: 33217568
[TBL] [Abstract][Full Text] [Related]
15. Berberine-photodynamic therapy sensitizes melanoma cells to cisplatin-induced apoptosis through ROS-mediated P38 MAPK pathways.
Wang X; Gong Q; Song C; Fang J; Yang Y; Liang X; Huang X; Liu J
Toxicol Appl Pharmacol; 2021 May; 418():115484. PubMed ID: 33716044
[TBL] [Abstract][Full Text] [Related]
16. Photosensitiser functionalised luminescent upconverting nanoparticles for efficient photodynamic therapy of breast cancer cells.
Buchner M; García Calavia P; Muhr V; Kröninger A; Baeumner AJ; Hirsch T; Russell DA; Marín MJ
Photochem Photobiol Sci; 2019 Jan; 18(1):98-109. PubMed ID: 30328457
[TBL] [Abstract][Full Text] [Related]
17. Photodynamic inactivation of circulating tumor cells: An innovative approach against metastatic cancer.
Raschpichler M; Preis E; Pinnapireddy SR; Baghdan E; Pourasghar M; Schneider M; Bakowsky U
Eur J Pharm Biopharm; 2020 Dec; 157():38-46. PubMed ID: 33059005
[TBL] [Abstract][Full Text] [Related]
18. Effects of LED-Based photodynamic therapy using red and blue lights, with natural hydrophobic photosensitizers on human glioma cell line.
Jamali Z; Hejazi SM; Ebrahimi SM; Moradi-Sardareh H; Paknejad M
Photodiagnosis Photodyn Ther; 2018 Mar; 21():50-54. PubMed ID: 29126958
[TBL] [Abstract][Full Text] [Related]
19. Nano-delivery vehicle based on chlorin E6, photodynamic therapy, doxorubicin chemotherapy provides targeted treatment of HER-2 negative, ανβ3-positive breast cancer.
He Z; Jiang H; Zhang X; Zhang H; Cui Z; Sun L; Li H; Qian J; Ma J; Huang J
Pharmacol Res; 2020 Oct; 160():105184. PubMed ID: 32946931
[TBL] [Abstract][Full Text] [Related]
20. Berberine hydrochloride IL-8 dependently inhibits invasion and IL-8-independently promotes cell apoptosis in MDA-MB-231 cells.
Li X; Zhao SJ; Shi HL; Qiu SP; Xie JQ; Wu H; Zhang BB; Wang ZT; Yuan JY; Wu XJ
Oncol Rep; 2014 Dec; 32(6):2777-88. PubMed ID: 25335112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
